Innovent Biologics, Inc. (IVBXF)
USD 6.88
(25.23%)
USD 6.88
(25.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -660.68 Million CNY | 60.64% |
| 2022 | -1.74 Billion CNY | 39.67% |
| 2021 | -2.37 Billion CNY | -295.92% |
| 2020 | -704.73 Million CNY | 53.42% |
| 2019 | -1.57 Billion CNY | 72.54% |
| 2018 | -5.73 Billion CNY | -802.9% |
| 2017 | -597.72 Million CNY | -40.05% |
| 2016 | -454.06 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -44.92 Million USD | 0.0% |
| 2023 Q1 | -39.79 Million USD | 78.11% |
| 2023 FY | - CNY | 60.64% |
| 2023 Q4 | -51.11 Million USD | -0.62% |
| 2023 Q3 | -50.79 Million USD | -38.58% |
| 2023 Q2 | -36.65 Million USD | 7.89% |
| 2022 Q2 | -167.24 Million USD | 0.0% |
| 2022 FY | - CNY | 39.67% |
| 2022 Q4 | -181.77 Million USD | -68.61% |
| 2022 Q3 | -107.8 Million USD | 35.54% |
| 2021 FY | - CNY | -295.92% |
| 2021 Q4 | -227.77 Million USD | 0.0% |
| 2021 Q2 | -111.83 Million USD | 0.0% |
| 2020 FY | - CNY | 53.42% |
| 2020 Q4 | 73.5 Million USD | 0.0% |
| 2020 Q2 | -83.36 Million USD | 0.0% |
| 2019 Q4 | -149.78 Million USD | 0.0% |
| 2019 FY | - CNY | 72.54% |
| 2019 Q2 | -101.34 Million USD | 0.0% |
| 2018 FY | - CNY | -802.9% |
| 2017 FY | - CNY | -40.05% |
| 2016 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.06 Million USD | -21469.721% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -18526.568% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -28820.428% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -3703.592% |
| GB Sciences, Inc. | -1.41 Million USD | -46430.811% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 174494.738% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -5402500.376% |
| Skye Bioscience, Inc. | -13.54 Million USD | -4776.778% |
| Zenith Capital Corp. | -8.6 Million USD | -7577.016% |
| Agentix Corp. | -1.37 Million USD | -48063.376% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -16909.0% |
| Biomind Labs Inc. | -1.03 Million USD | -63762.031% |
| ContraFect Corporation | -64.99 Million USD | -916.453% |
| CSL Limited | 4.78 Billion USD | 113.796% |
| CytoDyn Inc. | -18.02 Million USD | -3564.563% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 9825858.477% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -104371.495% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -1093.885% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -179814.547% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -42911.909% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -70414.404% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 802.57% |
| SQZ Biotechnologies Company | -64.14 Million USD | -930.049% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -44318.359% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -830.069% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -24883.815% |
| Mesoblast Limited | -62.38 Million USD | -958.963% |
| Marizyme, Inc. | -34.28 Million USD | -1827.234% |
| Genus plc | 73.7 Million USD | 996.45% |
| Pharming Group N.V. | 9.87 Million USD | 6789.116% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -7431.737% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -47030.848% |
| IMV Inc. | -35.52 Million USD | -1759.856% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -28330.946% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -127433.848% |
| ONE Bio Corp. | 13.61 Million USD | 4953.316% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -1269.946% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 18596.193% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -22742.653% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -9125.787% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -2642636.0% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -4063.169% |
| Alpha Cognition Inc. | -9.7 Million USD | -6707.245% |
| Enzolytics Inc. | -2.12 Million USD | -31034.542% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | -205.84% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 54387.921% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 7562.151% |
| Genscript Biotech Corporation | -248.71 Million USD | -165.634% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -11043.433% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -276163.433% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -26905.703% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -375236.686% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -34294.306% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -9892.926% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -14496.897% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -17535.08% |
| Helix BioMedix, Inc. | -1.04 Million USD | -63044.072% |
| EV Biologics, Inc. | -1.26 Million USD | -52040.109% |
| Q BioMed Inc. | -617.62 Thousand USD | -106871.187% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -37653.393% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -1566.843% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | -8646.559% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -26306.636% |
| HST Global, Inc. | -5303.00 USD | -12458583.764% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -32018.814% |
| Halberd Corporation | -74.27 Thousand USD | -889362.701% |
| Resverlogix Corp. | -11.74 Million USD | -5526.673% |
| Cell Source, Inc. | -4.27 Million USD | -15363.545% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -43977.747% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.11 Million USD | -10708.483% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -3792357.379% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -1.03 Million USD | -63746.725% |
| Kadimastem Ltd | -2.62 Million USD | -25074.851% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -173938.249% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -364741.403% |
| LadRx Corporation | 412.28 Thousand USD | 160350.119% |
| Regen BioPharma, Inc. | 1.46 Million USD | 45168.474% |
| Affymax, Inc. | -14.29 Million USD | -4521.784% |
| Itoco Inc. | -1.86 Million USD | -35249.693% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -59101.075% |
| Mobile Lads Corp. | -2.24 Million USD | -29379.568% |
| International Stem Cell Corporation | 202 Thousand USD | 327171.287% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | -17194.727% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -835901.974% |
| Qrons Inc. | -40.08 Thousand USD | -1648272.047% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -135933.339% |
| SYBLEU INC | -141.57 Thousand USD | -466580.323% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 125364.062% |
| Rebus Holdings, Inc. | -951 Thousand USD | -69372.555% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -62110.714% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1254998.784% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -26735.997% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -1741.936% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -1468086.667% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -24030.168% |
| Neutra Corp. | -181.24 Thousand USD | -364421.344% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -3177.365% |
| PureTech Health plc | -11.62 Million USD | -5582.326% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -3177.59% |
| IXICO plc | -707 Thousand USD | -93348.939% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -8497.059% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -1266.574% |
| CSL Limited | 4.73 Billion USD | 113.959% |
| Cellectis S.A. | -92.63 Million USD | -613.204% |